Wistuba I I, Sugio K, Hung J, Kishimoto Y, Virmani A K, Roa I, Albores-Saavedra J, Gazdar A F
Simmons Cancer Center, University of Texas Southwestern Medical Center, Dallas 75235, USA.
Cancer Res. 1995 Jun 15;55(12):2511-5.
Although gallbladder carcinoma is one of the most frequent neoplasms in Chile, there is limited information about the molecular changes involved in its pathogenesis. We investigated the incidence of ras gene mutations and loss of heterozygosity (LOH) at the following genes/loci: p53, DCC, rb, 5q 3p, 8p, and 9p. We precisely microdissected 194 relevant areas from paraffin-embedded microslides from 25 gallbladder carcinomas and their accompanying nonneoplastic lesions (which were present in 15 cases) from patients in Chile. The specimens were analyzed by PCR-based assays for LOH, and we designed a RFLP method for ras mutations and immunohistochemistry for p53 protein overexpression. We determined that LOH at p53 (91%), 9p (50%), 8p (44%) and DCC (31%) are frequent events and that LOH at p53, 9p, and DCC are early events, while ras mutations and LOH at 3p, rb, and 5q occurred occasionally. LOH at p53 occurred more frequently and earlier than protein overexpression. The mean number of mutations present in invasive carcinomas was 2.1, and in six cases, LOH at the p53 gene was the sole mutation detected. The same allele was lost in 61 (93%) of 71 nonneoplastic foci as in the corresponding invasive carcinomas for all four mutations studied. The odds of this occurring by chance are approximately 4 x 10(-15). Although clonality cannot be excluded, allelic loss appears to be highly directed, but the mechanism for allele-specific mutations remains to be determined.
尽管胆囊癌是智利最常见的肿瘤之一,但关于其发病机制中涉及的分子变化的信息有限。我们研究了以下基因/位点的ras基因突变和杂合性缺失(LOH)的发生率:p53、DCC、rb、5q、3p、8p和9p。我们从智利患者的25例胆囊癌及其伴随的非肿瘤性病变(15例中存在)的石蜡包埋微切片中精确显微切割了194个相关区域。通过基于PCR的方法分析标本的LOH,并设计了一种用于ras突变的RFLP方法和用于p53蛋白过表达的免疫组织化学方法。我们确定p53(91%)、9p(50%)、8p(44%)和DCC(31%)的LOH是常见事件,并且p53、9p和DCC的LOH是早期事件,而ras突变以及3p、rb和5q的LOH偶尔发生。p53的LOH比蛋白过表达更频繁且更早出现。浸润性癌中存在的平均突变数为2.1,在6例中,p53基因的LOH是检测到的唯一突变。在所有研究的四个突变中,71个非肿瘤性病灶中有61个(93%)与相应的浸润性癌丢失了相同的等位基因。这种情况偶然发生的几率约为4×10⁻¹⁵。尽管不能排除克隆性,但等位基因缺失似乎是高度定向的,但等位基因特异性突变的机制仍有待确定。